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Probiotics are dietary supplements containing potentially beneficial bacteria or yeasts. They 
are administered in different quantities that allow for colon colonization. These products help 
in stimulating health by promoting flora and also suppressing the pathologic colonization and 
disease spread. Initially, probiotics were used for the management of intestinal tract problems. 
But, nowadays its use has been proved in strengthening the immune system to combat 
allergies, stress, exposure to toxic substances and other diseases. There are few studies that 
reported anticariogenic effects of probiotics and their use in the treatment of periodontal 
disease and halitosis. However, data is still sparse on the action and role of probiotics in the 
oral cavity. More information is needed on the colonization of probiotics in the mouth and 
their possible effect on and within oral biofilm. The present review tries to briefly outline the 
potential role of probiotics in improving oral and dental health. 
1. Introduction  
The oral cavity is a complex ecosystem which harbours an 
astonishing variety of microbial species. Recently, Aas et al. have 
found more than 700 species occupying specific ecological niches 
in the oral cavity [1].The wide range in pH, nutrient availability, 
shedding and non-shedding surfaces, salivary and crevicular 
fluids select localized, discrete microbial climax communities to 
fluctuate in composition and metabolic activity but reach a kind 
of homeostasis in balance with the host. Changes in the 
environment whether imposed by illness, debility, behaviour, diet, 
or medications disturb the homeostasis and lead to endogenous 
infections or susceptibility to exogenous infections. 
Antimicrobial therapy is the most effective way to combat 
infections, but side effects like diarrhoea, dermatitis and anti-
microbial resistance, are associated with the use of these 
therapeutic agents. These are some reasons that make researchers 
to search for some other possibility in the treatment of infection. 
Bacteriotherapy and Probiosis is an alternate and promising way 
to fight infections by using harmless bacteria to displace 
pathogenic microorganisms. 
A literature search in Pub-Med database was performed for 
English language articles, using the following search terms: 
probiotics, prebiotics, lactic acid bacteria, dental diseases, oral 
candidiasis, and oral health; no restrictions were used for 
publication dates. 
 
1.1 History of probiotics 
 
The idea of probiotics dates back to the first decade of 1900 when 
the Ukrainian bacteriologist and Nobel Laureate Ilya Metchnikof 
(1908), while studying the flora of the human intestine developed  
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a theory that senility is caused by poisoning of the body by the 
products of some of these bacteria. The bacteria in fermented  
products could compete with microbes that are injurious to the 
host and thus are beneficial for health. 
The term probiotic, which literally means “for life” was originally 
proposed in 1960 by Lilley and Stillwell. Mann and Spoering in 
1974 discovered that the fermented yogurt reduces the blood 
serum cholesterol. The first probiotic species introduced into 
research were Lactobacillus acidophilus by Hull et al. in 1984 
and Bifidobacterium bifidum by Holcombh et al. in 1991[2]. 
The World Health Organization and the Food and Agriculture 
Organization of the United Nations have defined probiotics as 
"live microorganisms, which, when administered in adequate 
amounts, confer a health benefit on the host." They are also called 
"friendly bacteria" or "good bacteria". WHO in 1994 described 
the probiotics as next most important thing in immune defence 
system following development of antibiotic resistance. These 
incidences paved way for a new concept of probiotics in medicine 
and dentistry [3,4] 
Prebiotics are non-digestible food ingredients which includes 
inulin, fructo-oligosaccharides (FOS), galacto-oligosaccharide 
and lactulose [5]. They support the growth of beneficial bacteria 
and reduce harmful or potentially harmful bacteria in the intestine 
[6]. This reduces the risk of conditions such as infectious 
diarrhoea and general intestinal malaise. 
Probiotics and prebiotics simultaneously present in a product are 
called either Synbiotics or Eubiotics. Such a combination aids 
survival of administered probiotics and facilitates its inoculation  
 
 
into the colon. The concept of synbiotics may reduce the dose, 
frequency, or duration of each treatment. 
 
1.2 Composition of probiotics 
Probiotics can be varied. They can be yeast, bacteria or moulds. 
But most commonly, bacterial species are predominant. 
Some of the species are [7]: 
1. Lactic acid producing bacteria (LAB): Lactobacillus, 
bifidobacterium, streptococcus. 
2. Non lactic acid producing bacterial species: Bacillus, 
propionibacterium 
3. Non-pathogenic yeasts: Saccharomyces 
4. Non spore forming and non-flagellated rod or coccobacilli 
The lactobacillus species help in production of enzymes to digest 
and metabolize proteins and carbohydrates. Important probiotic 
microbial species useful in oral cavity are L. acidophilus, L. 
casei, L. rhamnosus GC, L. sporogens, L. bulgaricus, L. 
johnsonii, L. termophilus, L. bifidum, L. reuteri, L. salivaricus, L. 
paracasei, S. thermophilus, S. salivarius, W. cibaria and 
bifidobacterium. They aid in synthesis of vitamin B, vitamin K 
and facilitates breakdown of bile salts. They are usually dispensed 
in gel, paste, powder and liquid forms. Most common vehicles for 
probiotics in oral health include lozenges, tablets, yoghurt, 
cheese, milk and mouth rinse [8]. 
 
 
1.3 General health and probiotics 
Probiotics have been successfully used to control gastrointestinal 
disease, urinary tract infections, cancer risk reduction, to alleviate 
symptoms of allergy and disease with immunological pathology. 
Probiotics can improve patient condition in medical disorders 
such as diarrhoea, gastroenteritis, short-bowel syndrome, 
inflammatory intestinal diseases, cancer, immune depressive 
states, inadequate lactase digestion, paediatric allergies, growth 
retardation, hyper-lipidaemia, liver diseases, infections with 
Helicobacter pylori, genitourinary tract infections, and others; all 
such findings have been supported by several studies 
demonstrating improved results after using probiotics[9,10]. 
It is not fully clear how probiotics exert their beneficial effects on 
health, but one of the most probable mechanisms of action is the 
modulation of immune responses via the mucosal immune system 
of the gut. There is evidence that certain bacteria activate Peyer’s 
patch T cells to drive the mucosal immune system via Toll-like 
receptors on antigen-presenting cells also at other sites of the 
human body such as the oral cavity. Promoting T helper type 1 
(Th1) cytokine responses and down regulating Th2 may influence 
distant mucosal sites [11]. 
 
1.4 Oral health and probiotics 
Probiotics has well proved its efficacy in the prevention and 
treatment of large number of medical conditions. But its use in 
oral health is still in infancy. Attachment, adhesion and oral 
colonization is one of the main prerequisite for obtaining 
beneficial effect of probiotics in oral cavity. Probiotics should 
adhere to dental tissues and should be a part of the oral biofilm to 
fight with the periodontopathic and cariogenic bacteria. The 
duration of their stay locally also is important for beneficial 
effect. Results of recent clinical trials have shown its cariostatic 
properties and also its effectiveness against periodontal infections.    
 
1.5 Mechanism of action of probiotics in oral cavity 
The oral cavity represents the first part of the gastrointestinal 
tract, there is every reason to believe that at least some probiotic 
mechanisms may also play a role in that part of the system. It may 
also be anticipated that resident probiotics could exist in the oral 
microflora, and that they may function in the complex ecosystem 
of dental plaque and in the formation and development of oral 
biofilm. Figure (1) illustrates some of the hypothetical 
mechanisms of probiotics in the oral cavity [12].  
i. Direct interaction in dental plaque 
1) Involvement in binding of oral micro-organisms to 
proteins (biofilm formation) 
2) Action on plaque formation and on its complex 
ecosystem by competing and intervening with bacteria-
to-bacteria attachments 
3) Involvement in metabolism of substrates  
4) Production of chemicals that inhibits oral bacteria. 
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ii. Indirect probiotic actions are also featured such as 
1) Modulating systemic immune function. 
 
2) Effect on local immunity 
3) Effect on non-immunologic defence mechanisms. 
4) Regulation of mucosal permeability. 
5) Probiotics as an antioxidant and by producing 
antioxidants. 
6) Prevent plaque formation by neutralizing the free 
electrons. 
1.6 Evidence for use of prebiotics in the oral cavity 
Review of literature revealed that only few studies have been 
conducted on the prevalence, role and effects of probiotic bacteria 
in the oral cavity. A study by Sookhee et al. with 3790 lactic acid 
bacterial strains, showed about 5 species expressed inhibitory 
effect against other microorganisms, including Candida. 
Antimicrobial potentials of bacteria are affected by pH, catalase, 
proteolytic enzymes and temperature. The study also paved way 
for recognition of L. paracasei and L. rhamnous strains 
prompting for further study [13]. 
 
i. Probiotics and cariogenic pathogens 
It has been now proved by a numbers of studies that probiotics 
can reduce the risk of occurrence of Streptococcus mutans in the 
oral cavity [14-16]. In an in vitro study, it was suggested that 
Lactobacillus rhamnosus GG can inhibit colonization by 
streptococcal cariogenic pathogens and therefore reduce tooth 
decay incidence in children [15]. 
Näse et al. reported a reduced tooth decay incidence in children 
taking probiotic L. rhamnosus GG-enriched milk versus a control 
group of children taking milk without probiotic enrichment [12]. 
Similar findings were observed by Ahola et al. after administering 
the same probiotic [15]. Nikawa et al. showed that bovine milk 
fermented with Lactobacillus reuteri was effective against S. 
mutans, resulting in a reduced risk for tooth decay [16]. Unlike 
Meurman et al.[17] and Nikawa et al.[16] , Montalto et al. 
reported an increased amount of lactobacillus in saliva, with no  
 
reduction of S. mutans level, when administering to their patients 
lactobacillus in a fluid form or in capsules to assess systemic 
effects [18]. 
Çaglar et al. in a comparative study of S. mutans reduction effects 
by several probiotic administration forms showed a reduced S. 
mutans level in patients receiving fluid or tablet probiotic forms 
[19]. In another study by Çaglar et al. S. mutans reduction effects 
were compared in subjects using probiotics, xylitol, or probiotics 
plus xylitol-enriched chewing gums, and a placebo control group; 
a reduced S. mutans level was observed in subjects using 
probiotics or xylitol-enriched chewing gum; no synergic effect 
was seen when combining both agents [20]. Probiotics effects 
were also assessed after administration in a pacifier including a 
tablet that was dissolved in mouth after 10 to 12-minute suction; a 
reduced S. mutans level versus control group was found [21]. 
Effects of an ice-cream containing Bifidobacterium lactison, S. 
mutans and lactobacillus level in saliva were assessed by Çaglar 
et al and a significantly reduced level was observed for S. mutans, 
but not for Lactobacillus [22]. Harini PM and Anegundi RT 
evaluated the efficacy of probiotic and chlorhexidine rinse on 45 
healthy children and found that probiotics mouth rinse was 
effective in reducing plaque accumulation and gingival 
inflammation [23]. Näse L et al. reported a significant caries 
reduction after 7 months consumption of probiotics milk in 3-4 
year old [14]. In another study in adult population, probiotic 
rinsing resulted in significant reduction of plaque accumulation 
and gingival inflammation [24]. 
 
 
ii. Probiotics and periodontal disease 
Taking into account the two major treatment strategies against 
periodontal diseases, namely the elimination of specific pathogens 
and the suppression of a destructive host response, the probiotic 
approach may add value in achieving these treatment goals. 
Figure 2 outlines the plausible mechanisms whereby probiotic 











Figure 2: Theoretical possibilities for probiotics to affect 
periodontal health. 
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The effect of probiotics tablets on gingivitis and different grades 
of periodontitis was studied by Grudianov et al. and it found that 
probiotics treatment resulted in better microbiota normalization 
than control group [26]. Krasse et al. showed a significantly 
reduced gingival index and bacterial plaque amount in patients 
treated with L. reuteri than in a placebo group and concluded that 
this probiotic was effective to reduce gingivitis and bacterial 
plaque deposition in patients with moderate-to-severe gingivitis 
[27]. According to Koll-Klais et al. high levels of Lactobacillus 
in microbiota caused an 82% and 65% inhibition in 
Porphyromonas gingivalis and Prevotella intermedia growth, 
respectively [28]. Twetman et al. used L. reuteri containing 
chewing gum in 42 healthy patients and assessed its effects on 
crevicular fluid volume, cytokine (interleukin-1β, interleukin-6, 
interleukin-10, and TNF-α) levels, and bleeding on probing. 
Crevicular fluid volume, as well as TNF-α and interleukin-8 
levels, and bleeding were significantly reduced [29]. Shimauchi et 
al. described a beneficial effect of probiotics tablets, containing 
lactobacillus salivarius WB21, in the treatment of periodontitis 
patients [30] 
Even though there is good number of studies indicating anti-
carcinogenic effect in intestines, there are no studies done over 
the effect of probiotics on premalignant and malignant conditions 
of oral cavity [18]. 
 
iii.Probiotics and halitosis  
Regular use of probiotics can help to control halitosis. The use of 
W. cibaria resulted in reduced levels of volatile sulfide 
components produced by Fusobacterium nucleatum [31]. This 
effect could be due to hydrogen peroxide production by W. 
cibaria which caused F. nucleatum inhibition. Streptococcus 
salivarius also suppress volatile sulfide compounds by competing 
for colonization areas with volatile sulfide-producing species 
[32]. 
 
2. Future of probiotic therapy 
A wide field in probiotic research is still unexplored. A number of 
questions like, is there any way for permanent colonization of 
probiotic in oral cavity, which is the best way to administer 
probiotics, how much is the optimum dose of probiotics for oral 
disease prevention, is it safe to prescribe probiotic to immune 
compromised patients, are yet to be answered. We would have to 
concentrate more on molecular, nano, biochemical, 
microbiological, immunological and engineering sciences to 
answer these questions.  
Advances in biomedical engineering will prove to be important in 
terms of the developing systems that deliver bacteria and/or 
nutritional factors to the host. These will include encapsulating 
probiotics, such that they rehydrate at specific sites, and encasing 
prebiotics in nano-aggregates that protect against stomach acid 
and deliver their payload when the pH reaches 7.4 [33]. 
At the macromolecular level, it will soon be possible to coat 
capsules with biosensors that detect the optimal conditions for 




be created to respond to specific triggers in a host (e.g., a 
pathogen’s toxin) and produce factors to counteract them. Such  
sensors are already being described, such as the repressor FucR in 
B. thetaiotaomicron, which responds to l-fucose availability [34].  
The Given Imaging’s PillCam is a good example of engineering 
technology in medicine. This tiny capsule is swallowed, and, as it 
passes through the host, it takes photographs of the mucosal 
tissues. In time, such devices will be controlled remotely, will 
have sensors and sampling devices, and will deliver payloads at 
the desired site. Such science fiction will become reality within 
10 years. 
To make these breakthroughs of value to patients, companies in 
the food, biotechnology, engineering, and pharmaceutical 
industries will have to learn from each other with regard to 
production of strains and their delivery-suitable formulations, 
while traditionally bureaucratic and slow-moving regulatory 
agencies will have to become visionary, proactive, and more 
adept at processing these new developments. Unless this happens, 
the great strides made in science may never reach the people who 




The therapeutic potential of probiotic bacteria is vast but is just 
beginning to be tapped due to the huge diversity of the 
commensal enteric microenvironment. The intestinal bacteria 
flora contributes significantly to the pathogenesis of large number 
of intestinal disorder, along with genetic susceptibility and 
mucosal immune dysregulation. But, nowadays probiotics have 
proven its effectiveness in treatment of various oral diseases like 
dental caries, gingivitis, periodontitis and oral ulcerations. 
Understanding probiotic action may permit modulation of the 
immune system, both locally and systemically. Knowledge of 
probiotics on the host immune system has entered a new and 
fascinating phase of research and progression in this field is likely 
to offer novel and useful means to modulate host immunity for 
protection from, or treatment of, a wide variety of oral diseases 
and disorders. 
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